Colorectal cancer
Conditions
Interventions
Non-Exposed group:none
Exposure group:Chinese Herbal Compound Granules
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, China.
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Colorectal cancer with definite pathological diagnosis and no evidence of distant metastasis, initially assessed as resectable colorectal cancer, clinical imaging stage I-III;(2) Patients who do not need neoadjuvant therapy after multidisciplinary discussion;(3) Age 18 to 85 years old, regardless of gender;(4) KPS score =70 points;(5) No history of colorectal cancer surgery or chemotherapy, no history of pelvic radiotherapy;(6) Patients read and sign the informed consent form of this study and agree to participate in this study.
Exclusion criteria
Exclusion criteria: (1) Patients who are receiving other types of anti-tumor or experimental therapy;(2) The patient is a pregnant or lactating woman;(3) Patients with severe cardiovascular and cerebrovascular disease complications, active hepatitis, and severe liver and kidney dysfunction;(4) Patients with complete intestinal obstruction who cannot be treated with oral drugs;(5) People who are allergic to the ingredients of the drug tested in this study;(6) The researcher decides that it is not suitable to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First postoperative exhaust time; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome and cold and heat scale score;Assessment of quality of life;Postoperative first bowel movement time;Postoperative complication incidence rate; Number of days in hospital after surgery; | — |
Countries
China
Contacts
Public ContactYun Xu
Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, China.
Outcome results
None listed